A股異動 | 無視風險提示 江蘇吳中(600200.SH)三連板
格隆匯4月14日丨江蘇吳中(600200.SH)連續第三日漲停,現報7.15元,封單逾24萬手,暫成交6.6億元,最新總市值50.9億元。江蘇吳中昨日晚間發公吿稱,公司關注到在部分股票交流平台,有投資者將公司稱為“核污染防治概念股”、“防輻射概念股”。公司未生產和銷售“乃捷爾牌清輻寧膠囊”,也未生產其他核污染防治和防輻射類的產品。公吿還稱,今年1月30日,公司披露了《江蘇吳中實業股份有限公司2020年年度業績預虧公吿》,預計2020年年度實現歸屬於上市公司股東的淨利潤為-4.70億元至-5.40億元。敬請廣大投資者理性投資,注意投資風險。

Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.